CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE VS CARFILZOMIB-CYCLOPHOSPHAMIDE-DEXAMETHASONE INDUCTION: PLANNED INTERIM ANALYSIS OF THE RANDOMIZED FORTE TRIAL IN NEWLY DIAGNOSED MULTIPLE MYELOMA

被引：0
|
作者：
Gay, F. [1 ]
Scalabrini, D. Rota [2 ]
Belotti, A. [2 ]
Offidani, M. [2 ]
Tacchetti, P. [2 ]
Petrucci, M. T. [2 ]
Pautasso, C. [1 ]
Palmas, A. D. [2 ]
Siniscalchi, A. [2 ]
Grasso, M. [2 ]
Spadano, A. [2 ]
Giuliani, N. [2 ]
Ballanti, S. [2 ]
Patriarca, F. [2 ]
Canepa, L. [2 ]
Bernardini, A. [1 ]
Aquino, S. [2 ]
Gamberi, B. [2 ]
Zambello, R. [2 ]
Ledda, A. [2 ]
Montefusco, V. [2 ]
Omede, P. [1 ]
Galli, M. [2 ]
Cavo, M. [2 ]
Palumbo, A. [1 ,3 ,4 ]
Musto, P. [2 ]
Boccadoro, M. [1 ]
机构：
[1] Univ Torino, Div Hematol, Myeloma Unit, Turin, Italy
[2] Italian Multiple Myeloma Network, Gimema, Italy
[3] Takeda Pharmaceut Co Employee, Turin, Italy
[4] Takeda Pharmaceut Co, Zurigo, Switzerland
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S410
引用
收藏
页码：143 / 144
页数：2
相关论文
共 50 条
  • [1] Carfilzomib-lenalidomide-dexamethasone (KRd) vs carfilzomib-cyclophosphamide-dexamethasone (KCd) induction: Planned interim analysis of the randomized FORTE trial in newly diagnosed multiple myeloma (NDMM).
    Gay, Francesca Maria
    Scalabrini, Delia Rota
    Belotti, Angelo
    Offidani, Massimo
    Petrucci, Maria Teresa
    Esma, Fabrizio
    Palmas, Angelo D.
    Caravita, Tommaso
    Grasso, Mariella
    Aquino, Sara
    Gamberi, Barbara
    Zambello, Renato
    Ledda, Antonio
    Montefusco, Vittorio
    Omede, Paola
    Galli, Monica
    Cavo, Michele
    Palumbo, Antonio
    Musto, Pellegrino
    Boccadoro, Mario
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] INTERIM ANALYSIS OF CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE VS CARFILZOMIB-CYCLOPHOSPHAMIDE-DEXAMETHASONE IN THE FORTE TRIAL
    Gay, F.
    Spadano, A.
    Cavo, M.
    Caravita, T.
    Canepa, L.
    Giuliani, N.
    Spada, S.
    Patriarca, F.
    Morabito, F.
    Tacchetti, P.
    Narni, F.
    De Sabbata, G.
    De Santis, F.
    Pascarella, A.
    Palmieri, S.
    Liberati, A. M.
    Pisani, F.
    Genuardi, M.
    Tosi, P.
    Annibali, O.
    Ruggeri, M.
    Curci, P.
    De Rosa, L.
    Palumbo, A.
    Musto, P.
    Boccadoro, M.
    HAEMATOLOGICA, 2017, 102 : 1 - 1
  • [3] Carfilzomib-Lenalidomide-Dexamethasone (KRd) Induction-Autologous Transplant (ASCT)-Krd Consolidation Vs KRd 12 Cycles Vs Carfilzomib-Cyclophosphamide-Dexamethasone (KCd) Induction-ASCT-KCd Consolidation: Analysis of the Randomized Forte Trial in Newly Diagnosed Multiple Myeloma (NDMM)
    Gay, Francesca
    Cerrato, Chiara
    Scalabrini, Delia Rota
    Galli, Monica
    Belotti, Angelo
    Zamagni, Elena
    Ledda, Antonio
    Grasso, Mariella
    Angelucci, Emanuele
    Liberati, Anna Marina
    Tosi, Patrizia
    Pisani, Francesco
    Spada, Stefano
    Annibali, Ombretta
    Baraldi, Anna
    Omede, Paola
    Galieni, Piero
    Rizzi, Rita
    Pescosta, Norbert
    Ronconi, Sonia
    Vincelli, Donatella
    Cafro, Anna Maria
    Offidani, Massimo
    Palumbo, Antonio
    Musto, Pellegrino
    Cavo, Michele
    Boccadoro, Mario
    BLOOD, 2018, 132
  • [4] A Randomized Study of Carfilzomib-Lenalidomide-Dexamethasone Vs Carfilzomib-Cyclophosphamide-Dexamethasone Induction in Newly Diagnosed Myeloma Patients Eligible for Transplant: High Efficacy in High- and Standard- Risk Patients
    Gay, Francesca Maria
    Scalabrini, Delia Rota
    Belotti, Angelo
    Galli, Monica
    Zamagni, Elena
    Offidani, Massimo
    Oliva, Stefania
    Montefusco, Vittorio
    Zambello, Renato
    Ledda, Antonio
    Grasso, Mariella
    Aquino, Sara
    Esma, Fabrizio
    Tosi, Patrizia
    Pisani, Francesco
    Annibali, Ombretta
    Liberati, Anna Marina
    Baraldi, Anna
    Galieni, Piero
    Specchia, Giorgina
    Pescosta, Norbert
    Mancuso, Katia
    Paris, Laura
    Ribolla, Rossella
    Coha, Valentina
    Palumbo, Antonio
    Musto, Pellegrino
    Cavo, Michele
    Boccadoro, Mario
    BLOOD, 2017, 130
  • [5] Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma
    Korde, Neha
    Roschewski, Mark
    Zingone, Adriana
    Kwok, Mary
    Manasanch, Elisabet E.
    Bhutani, Manisha
    Tageja, Nishant
    Kazandjian, Dickran
    Mailankody, Sham
    Wu, Peter
    Morrison, Candis
    Costello, Rene
    Zhang, Yong
    Burton, Debra
    Mulquin, Marcia
    Zuchlinski, Diamond
    Lamping, Liz
    Carpenter, Ashley
    Wall, Yvonne
    Carter, George
    Cunningham, Schuyler C.
    Gounden, Verena
    Sissung, Tristan M.
    Peer, Cody
    Maric, Irina
    Calvo, Katherine R.
    Braylan, Raul
    Yuan, Constance
    Stetler-Stevenson, Maryalice
    Arthur, Diane C.
    Kong, Katherine A.
    Weng, Li
    Faham, Malek
    Lindenberg, Liza
    Kurdziel, Karen
    Choyke, Peter
    Steinberg, Seth M.
    Figg, William
    Landgren, Ola
    JAMA ONCOLOGY, 2015, 1 (06) : 746 - 754
  • [6] Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
    Tan, Carlyn Rose
    Derkach, Andriy
    Nemirovsky, David
    Ciardiello, Amanda
    Diamond, Benjamin
    Hultcrantz, Malin
    Hassoun, Hani
    Mailankody, Sham
    Shah, Urvi
    Maclachlan, Kylee
    Patel, Dhwani
    Lahoud, Oscar B. B.
    Landau, Heather J. J.
    Chung, David J. J.
    Shah, Gunjan L. L.
    Scordo, Michael
    Giralt, Sergio A. A.
    Lesokhin, Alexander
    Usmani, Saad Z. Z.
    Landgren, Ola
    Korde, Neha
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [7] Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
    Carlyn Rose Tan
    Andriy Derkach
    David Nemirovsky
    Amanda Ciardiello
    Benjamin Diamond
    Malin Hultcrantz
    Hani Hassoun
    Sham Mailankody
    Urvi Shah
    Kylee Maclachlan
    Dhwani Patel
    Oscar B. Lahoud
    Heather J. Landau
    David J. Chung
    Gunjan L. Shah
    Michael Scordo
    Sergio A. Giralt
    Alexander Lesokhin
    Saad Z. Usmani
    Ola Landgren
    Neha Korde
    Blood Cancer Journal, 13
  • [8] Carfilzomib-lenalidomide-dexamethasone vs lenalidomide-dexamethasone in relapsed multiple myeloma by previous treatment
    Dimopoulos, M. A.
    Stewart, A. K.
    Masszi, T.
    Spicka, I.
    Oriol, A.
    Hajek, R.
    Rosinol, L.
    Siegel, D.
    Mihaylov, G. G.
    Goranova-Marinova, V.
    Rajnics, P.
    Suvorov, A.
    Niesvizky, R.
    Jakubowiak, A.
    San-Miguel, J.
    Ludwig, H.
    Ro, S.
    Aggarwal, S.
    Moreau, P.
    Palumbo, A.
    BLOOD CANCER JOURNAL, 2017, 7 : e554 - e554
  • [9] Carfilzomib and dexamethasone induction with lenalidomide, clarithromycin and dexamethasone consolidation and lenalidomide maintenance for newly diagnosed multiple myeloma
    Forsberg, Peter A.
    Rossi, Adriana C.
    Boyer, Angelique
    Pearse, Roger N.
    Pekle, Karen A.
    Jayabalan, David
    Lakritz, Stephanie
    Flicker, Kari
    Ribadeneyra, Drew
    Liotta, Brielle
    Ely, Scott
    Boussi, Leora
    Allan, John N.
    Coleman, Morton
    Niesvizky, Ruben
    Mark, Tomer M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (12) : 1554 - 1562
  • [10] Results of the Phase III Randomized Iskia Trial: Isatuximab-Carfilzomib-Lenalidomide-Dexamethasone Vs Carfilzomib-Lenalidomide-Dexamethasone As Pre-Transplant Induction and Post-Transplant Consolidation in Newly Diagnosed Multiple Myeloma Patients
    Gay, Francesca
    Roeloffzen, Wilfried
    Dimopoulos, Meletios A.
    Rosinol, Laura
    van der Klift, Marjolein
    Mina, Roberto
    Oriol Rocafiguera, Albert
    Katodritou, Eirini
    Wu, Ka Lung
    Rodriguez Otero, Paula
    Hajek, Roman
    Antonioli, Elisabetta
    van Duin, Mark
    D'Agostino, Mattia
    Martinez-Lopez, Joaquin
    van Leeuwen-Segarceanu, Elena M.
    Tacchetti, Paola
    van de Donk, Niels W. C. J.
    Weisel, Katja
    Pour, Ludek
    Radocha, Jakub
    Belotti, Angelo
    Schjesvold, Fredrik
    Blade, Joan
    Einsele, Hermann
    Sonneveld, Pieter
    Boccadoro, Mario
    Broijl, Annemiek
    BLOOD, 2023, 142
12345